Skip to content

Single use vs reusable catheters in intermittent CatheterizatiOn for treatment of urinary retention: a Multicenter, Prospective, RandomizEd controlled, non-inferiority trial.

Single use vs reusable catheters in intermittent CatheterizatiOn for treatment of urinary retention: a Multicenter, Prospective, RandomizEd controlled, non-inferiority trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON19999
Enrollment
456
Registered
2020-01-14
Start date
2020-01-19
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary retention due to non-neurogenic and neurogenic causes

Interventions

Half of the participants will start using the reusable catheter after randomization. This catheter is developed for reuse and will be used for two weeks. The catheter will be stored in a container fil

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Male/Female patients = 16 years old - Diagnosed with urinary retention or significant post-void residue due to non-neurogenic or neurogenic causes - Expected chronic, but at least for a duration of twelve months, necessity for daily drainage of the urinary bladder - Be able to administer self CIC via the urethra daily and have at least two weeks of experience in CIC

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Age < 16 years - Temporary use of catheterization because of transient causes - Known significant urethral stricture which complicates CIC - Urinary tract stones - Bladder augmentation - Non-urethral catheterization - History of bladder cancer with active follow-up - The use of immunosuppressives for transplantation or auto-immune diseases - Neurocognitive disease which prevents complete comprehension of the study

Design outcomes

Primary

MeasureTime frame
The main objective of this trial is to determine whether reusable catheters are not less safe as single use catheters, measured by symptomatic UTIs.

Secondary

MeasureTime frame
Secondary objectives are adverse events like hospital admissions due to UTIs, changes in urine cultures/urinary microbiome, urethral damage/strictures, kidney/bladder stone formation and quality of life of the participants. Cost effectiveness and recommendations for practice will be provided.

Contacts

Public ContactBertil Blok

Erasmus Medical Center

b.blok@erasmusmc.nl06-25 67 73 37

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)